Credit Suisse’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.8M Buy
15,951
+46
+0.3% +$4.59K ﹤0.01% 1927
2023
Q4
$1.48M Buy
15,905
+1,056
+7% +$93K ﹤0.01% 2091
2023
Q3
$1.36M Buy
14,849
+395
+3% +$42.4K ﹤0.01% 2081
2023
Q2
$1.75M Sell
14,454
-953
-6% -$103K ﹤0.01% 1999
2023
Q1
$1.51M Buy
15,407
+530
+4% +$50.6K ﹤0.01% 2049
2022
Q4
$1.21M Buy
14,877
+3,196
+27% +$268K ﹤0.01% 2213
2022
Q3
$888K Buy
11,681
+1,481
+15% +$142K ﹤0.01% 2415
2022
Q2
$1.11M Sell
10,200
-48
-0.5% -$5.1K ﹤0.01% 2315
2022
Q1
$1.02M Buy
10,248
+1,020
+11% +$97.3K ﹤0.01% 2533
2021
Q4
$881K Sell
9,228
-299
-3% -$30K ﹤0.01% 3413
2021
Q3
$1.05M Sell
9,527
-1,374
-13% -$157K ﹤0.01% 3295
2021
Q2
$1.26M Buy
10,901
+1,175
+12% +$135K ﹤0.01% 3211
2021
Q1
$1.01M Sell
9,726
-812
-8% -$101K ﹤0.01% 3317
2020
Q4
$1.27M Buy
10,538
+3,062
+41% +$309K ﹤0.01% 3158
2020
Q3
$650K Sell
7,476
-730
-9% -$62.8K ﹤0.01% 3225
2020
Q2
$665K Buy
8,206
+286
+4% +$20.9K ﹤0.01% 3151
2020
Q1
$546K Sell
7,920
-6,876
-46% -$725K ﹤0.01% 3061
2019
Q4
$1.69M Buy
14,796
+4,648
+46% +$579K ﹤0.01% 2750
2019
Q3
$1.32M Buy
10,148
+1,219
+14% +$159K ﹤0.01% 2798
2019
Q2
$1.09M Sell
8,929
-417
-4% -$47.9K ﹤0.01% 2877
2019
Q1
$982K Sell
9,346
-1,777
-16% -$191K ﹤0.01% 2905
2018
Q4
$1.14M Sell
11,123
-1,753
-14% -$195K ﹤0.01% 2680
2018
Q3
$1.53M Buy
12,876
+110
+0.9% +$12.4K ﹤0.01% 2553
2018
Q2
$1.23M Buy
12,766
+171
+1% +$15.9K ﹤0.01% 2855
2018
Q1
$1.02M Buy
12,595
+985
+8% +$76.3K ﹤0.01% 2936
2017
Q4
$838K Sell
11,610
-2,455
-17% -$167K ﹤0.01% 3121
2017
Q3
$865K Buy
14,065
+7,646
+119% +$466K ﹤0.01% 3203
2017
Q2
$388K Sell
6,419
-6,074
-49% -$388K ﹤0.01% 3320
2017
Q1
$816K Sell
12,493
-2,155
-15% -$153K ﹤0.01% 3012
2016
Q4
$1.03M Sell
14,648
-2,691
-16% -$171K ﹤0.01% 3003
2016
Q3
$1.09M Sell
17,339
-528
-3% -$32.6K ﹤0.01% 2883
2016
Q2
$1.08M Buy
17,867
+3,034
+20% +$166K ﹤0.01% 2862
2016
Q1
$738K Buy
14,833
+9,588
+183% +$477K ﹤0.01% 2955
2015
Q4
$281K Sell
5,245
-5,827
-53% -$292K ﹤0.01% 3713
2015
Q3
$497K Sell
11,072
-953
-8% -$47.5K ﹤0.01% 3391
2015
Q2
$658K Sell
12,025
-8,045
-40% -$398K ﹤0.01% 3520
2015
Q1
$954K Buy
20,070
+4,461
+29% +$190K ﹤0.01% 3013
2014
Q4
$655K Buy
15,609
+2,819
+22% +$111K ﹤0.01% 3506
2014
Q3
$452K Buy
12,790
+1,392
+12% +$49.2K ﹤0.01% 3710
2014
Q2
$390K Sell
11,398
-247
-2% -$7.97K ﹤0.01% 3971
2014
Q1
$403K Sell
11,645
-4
-0% -$133 ﹤0.01% 3879
2013
Q4
$411K Buy
+11,649
New +$381K ﹤0.01% 3879
2013
Q3
Sell
-9,036
Closed -$250K 4375
2013
Q2
$250K Buy
+9,036
New +$239K ﹤0.01% 3739

Other funds holding USPH

Credit Suisse's USPH Position: Q1 2024 in Review

Credit Suisse increased its US Physical Therapy (USPH) stake by 0.29% in Q1 2024, buying an estimated $4.59K and bringing the position to 15,951 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1927.

Credit Suisse first reported a position in USPH in Q2 2013 and has held it in 43 quarters since. 236 funds tracked by Wall St. Rank hold USPH as of Q1 2024.

  • Credit Suisse held 15,951 shares of US Physical Therapy worth $1.8M as of Q1 2024.
  • Credit Suisse bought 46 US Physical Therapy shares in Q1 2024, an estimated $4.59K.
  • US Physical Therapy made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1927 holding.
  • Credit Suisse first reported a position in US Physical Therapy in Q2 2013 and has held it in 43 quarters since.
  • 236 funds tracked by Wall St. Rank held US Physical Therapy as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.